Skip to main content

Evogene Ltd.

EVGN
Exchange
Nasdaq
Industry
Agricultural Chemicals
SEC CIK
0001574565

In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Evogene Ltd. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of EVGN: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders3943+4
Shares6.31M6.02M−284.2K (−4.5%)
Value$16.7M$10.0M−$6.65M (−39.9%)

New holders (10)

Institutions that held Evogene Ltd. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to EVGN in Q4 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC143,093$235.0K0.00%
Eidelman Virant Capital113,000$185.0K0.07%
Credit Suisse AG57,283$94.0K0.00%
Walleye Capital LLC25,039$41.0K0.00%
Group One Trading, L.P.23,063$38.0K0.00%
Walleye Trading LLC13,840$23.0K0.00%
HRT Financial LP13,446$22.0K0.00%
Tower Research Capital LLC (TRC)8,206$13.0K0.00%
Snowden Capital Advisors LLC200$00.00%
Edge Wealth Management LLC50––

Sold out (6)

Institutions that held Evogene Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of EVGN in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
PDT Partners, LLC77,400$204.0K
Squarepoint Ops LLC45,299$120.0K
Jump Financial, LLC16,800$44.0K
Phoenix Wealth Advisors6,000$16.0K
Barclays PLC50$0
Clal Insurance Enterprises Holdings Ltd1$0